Cargando…
Mitochondrial Involvement in Cisplatin Resistance
Cisplatin is one of the worldwide anticancer drugs and, despite its toxicity and frequent recurrence of resistance phenomena, it still remains the only therapeutic option for several tumors. Circumventing cisplatin resistance remains, therefore, a major goal for clinical therapy and represents a cha...
Autores principales: | Cocetta, Veronica, Ragazzi, Eugenio, Montopoli, Monica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678541/ https://www.ncbi.nlm.nih.gov/pubmed/31295873 http://dx.doi.org/10.3390/ijms20143384 |
Ejemplares similares
-
The Pentose Phosphate Pathway and Its Involvement in Cisplatin Resistance
por: Giacomini, Isabella, et al.
Publicado: (2020) -
Cisplatin liposome and 6-amino nicotinamide combination to overcome drug resistance in ovarian cancer cells
por: Catanzaro, Daniela, et al.
Publicado: (2018) -
Contribution of Mitochondrial Activity to Doxorubicin-Resistance in Osteosarcoma Cells
por: Giacomini, Isabella, et al.
Publicado: (2023) -
Cisplatin resistance can be curtailed by blunting Bnip3-mediated mitochondrial autophagy
por: Vianello, Caterina, et al.
Publicado: (2022) -
Resveratrol as Chemosensitizer Agent: State of Art and Future Perspectives
por: Cocetta, Veronica, et al.
Publicado: (2021)